Mon. Mar 31st, 2025

SCFA biotherapy delays diabetes in humanized gnotobiotic mice by remodeling mucosal homeostasis and metabolome – Nature.com

Byadmin

Mar 28, 2025

By admin

Related Post

COVID-19 Vaccination Acceptance Among the Diabetic Population in the Northwestern Region of Romania: Insights From an Autofill Survey – Cureus

Mar 31, 2025 admin

Indigenous people need culturally tailored programs to combat type 2 diabetes – MJA Insight

Mar 31, 2025 admin

Oral GLP-1 Receptor Agonist Reduces CV Risk – Medscape

Mar 30, 2025 admin

Leave a Reply Cancel reply

You missed

COVID-19 Vaccination Acceptance Among the Diabetic Population in the Northwestern Region of Romania: Insights From an Autofill Survey – Cureus

Mar 31, 2025 admin

Indigenous people need culturally tailored programs to combat type 2 diabetes – MJA Insight

Mar 31, 2025 admin

Oral GLP-1 Receptor Agonist Reduces CV Risk – Medscape

Mar 30, 2025 admin

ACC 2025: Semaglutide Significantly Improves Walking Distance, Symptoms, QOL for Individuals with PAD and Diabetes – Pharmacy Times

Mar 30, 2025 admin